For in vitro diagnostic use. Others 6AM IVD 6AM CPS_000001 6-Acetylmorphine Enzyme Immunoassay 08 240 035 190 8 240 035 190 08240035190 8240035190 08240035190 6AM, 200T, cobas c, PCh 6AM 00850624008001 Reagents, kits 200 tests cobas c 501/502 true 09 067 795 190 9 067 795 190 09067795190 9067795190 09067795190 6AM, 240T, cobas c pack green, PCh 6AM Reagents, kits 240 tests cobas c 303/503 true 0008240035190c501 6AM 6-Acetylmorphine Enzyme Immunoassay en 2 FF00000004F1830E FF00000002586E0E 08240035190 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe 6‑Acetylmorphine Enzyme Immunoassay is intended for the qualitative and semi‑quantitative determination of 6‑acetylmorphine in human urine at a cutoff value of 10 ng/mL. The assay is designed for prescription use with the Roche cobas c 501/502 automated clinical chemistry analyzers.The assay provides only a preliminary analytical result. A more specific alternative analytical chemistry method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC‑MS or LC‑MS) are the preferred confirmatory methods.LREFUrine Testing for Drug of Abuse, National Institute on Drug Abuse (NIDA) Research Monograph 73 (1986).,LREFMandatory Guidelines for Federal Workplace Drug Testing Program, National Institute on Drug Abuse, Federal Register 1988;53(69):11970.Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary test result is positive. en 0209067795190c503 6AM 6-Acetylmorphine Enzyme Immunoassay en 2 FF0000000682870E FF000000052D9A0E 09067795190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThe 6‑Acetylmorphine Enzyme Immunoassay is an in vitro diagnostic test intended for the qualitative and semi‑quantitative determination of 6‑acetylmorphine in human urine at a cutoff value of 10 ng/mL. The assay is designed for prescription use with the Roche cobas c automated clinical chemistry analyzers.The assay provides only a preliminary analytical result. A more specific alternative analytical chemistry method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC‑MS or LC‑MS) are the preferred confirmatory methods.LREFUrine Testing for Drug of Abuse, National Institute on Drug Abuse (NIDA) Research Monograph 73 (1986).,LREFMandatory Guidelines for Federal Workplace Drug Testing Programs. Fed Regist 2017 Jan 23;82:7920-7970.Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary test result is positive. en

User profile

Select your user profile

6AM

Overview

Ordering information

Technical documents

Access important product documentation including relevant certificates and other resources.

Compatible products

Related products

Contact us